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Antimicrobial propertyAbstract Novel binuclear metal complexes of general formula [M2(PymL)X3] (where:
M= Cu(II), Ni(II), Co(II) or Zn(II); X = Cl or CH3CO2
 and PymL= C13H17N4O6) were syn-
thesized by template condensation of Schiff base (L) derived from glycine using 2,3-butanedione, 5-
methyl-2,6-pyrimidine-dione and metal chloride/acetate salt in 1:1:2 stoichiometric ratio. Synthe-
sized compounds were characterized by elemental analysis, conductance measurement, magnetic
measurement, IR, UV–visible, 1H NMR, 13C NMR, EPR and ESI-MS spectral studies. IR spectral
data suggest that Schiff base (L) behaves as tetradentate ligand with two nitrogen and two oxygen
donor sites of the azomethine group and carboxylic group, respectively and 5-methyl-2,6-pyrimi-
dine-dione behaves as tridentate ligand with two oxygen atoms of the carbonyl group and one nitro-
gen atom of pyrimidine ring as binding sites. Physico-chemical data suggest octahedral geometry
and non-electrolytic nature of metal complexes. The compounds were evaluated for their antimicro-
bial property by in vitro antimicrobial screening against bacteria Staphylococcus aureus, Bacillus
subtilis, Escherichia coli and Salmonella typhi and fungi Candida albicans and Candida parapsilosis.
The results indicate that metal complexes exhibit more activity than free Schiff base (L) against
studied bacteria and fungi.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
After the discovery of cis-platin, there has been considerable
exploration of other transition metal complexes. Enormous
interest of coordination compounds of transition metal ions
is due to their various biological signiﬁcance as well as unique
catalytic, photochemical and optical properties (Parashar
et al., 1988; Suslick and Reinert, 1985; Gamba et al., 2013;
In vitro antibacterial and antifungal activities of binuclear transition metal complexes 49Prakash and Natarajan, 2003; Harriman et al., 2007; Singh
and Singh, 2014). Recently synthesized transition metal com-
plexes have been used for the study of biological activities
viz. antibacterial, antifungal, toxicity and DNA interaction
(Srivastava et al., 2014; Bagihalli and Patil, 2010; Alagha
et al., 2011; Singh and Pal, 2010; Singh and Srivastava, 2010;
Tabassum et al., 2001; Patel et al., 2011). Pyrimidines, being
an integral part of DNA and RNA, play an essential role in
several biological processes and have considerable chemical
and pharmacological importance. Due to multifunctional
coordinating ability of pyrimidines and its derivatives, they
have been used for the synthesis of mononuclear and binuclear
transition metal complexes (Khali et al., 2002; Mastropietro
et al., 2008; Weitzer and Brooker, 2005; Lumme and
Knuuttilla, 1995). There are many bibliographic data available
which display coordination modes of pyrimidine moiety (Faus
et al., 1993; Colacio et al., 1995; Masoud et al., 2004). Most of
the transition metal complexes containing purine or pyrimi-
dine base have been used to understand biological phenomena
as well as to get new biologically active metallodrugs (Sikova
and Rowan, 2005; Navarro and Lippert, 2001; Sharaby
et al., 2007; Sonmez et al., 2010). Amino acid Schiff base read-
ily forms complexes with metal ions which play an important
role as the basic compounds for modelling more complicated
Schiff base (Pyrz et al., 1985; Martell and Szpoganicz, 1989;
Aminabhavi et al., 1985; Arbaoui et al., 2011). Importance
of coordination chemistry of amino acid Schiff bases and other
Schiff bases is clear by the study of antifungal, antibacterial
and anticancer activities of some reported mononuclear and
binuclear complexes (Patil et al., 2010; Gudasi et al., 2006;
Tabassum et al., 2010; Shi et al., 2008; Revenco et al., 2011;
Singh et al., 2012; Singh and Srivastava, 2012). The primeO
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Scheme 2 Synthesis of binuclear metaim of the present work is to prepare binuclear metal com-
plexes of ONNO Schiff base (L) derived from glycine using
2,3-butanedione and 5-methyl-2,6-pyrimidine-dione. Synthe-
sized compounds were characterized by various analytical
and spectral studies like elemental analysis, magnetic moment
measurement, molar conductance measurement, IR, UV–visi-
ble, NMR, EPR and ESI-MS. In vitro antibacterial and anti-
fungal activities of synthesized compounds against some
speciﬁc microbes were also studied.
2. Experimental
2.1. Reagents
All chemicals and solvents were of AR grade and used without
further puriﬁcation. MeOH, EtOH, diethyl ether, DMF,
DMSO and metal salts were purchased from Qualigens. 2,3-
butanedione was purchased from Aldrich. Glycine and 5-
methyl-2,6-pyrimidine-dione were purchased from CDH.
2.2. Synthesis of Schiff base (L)
To an aqueous solution of glycine (20 mmol, 1.50 g), ethanolic
solution of 2,3-butanedione (10 mmol, 0.87 ml) was added
drop-wise with constant stirring. The resulting solution was
stirred at 55 C for 45 min and reﬂuxed at 60 C for 1 h. The
completion of reaction was monitored by thin layer chroma-
tography (TLC). The solution was cooled in refrigerator over-
night. Yellow coloured solid product (L) was precipitated,
ﬁltered off, washed with water, MeOH, EtOH and diethyl
ether and dried in vacuum desiccator over anhydrous calcium
chloride (Scheme 1).H / H2O,
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al complexes [M2(PymL)X3] (1–4).
Table 1 IR spectral data (t, cm1) of the Schiff base (L) and metal complexes (1–4).
Compounds t(C‚N) azo. t(C‚O) carbox. t(C‚O) pym. t(‚CAN) pym. t(MAN) t(MAO)
(L) 1618 1768 – – – –
[Cu2(PymL)Cl3] (1) 1594 1738 1664 1248 498 526
[Ni2(PymL)Cl3] (2) 1592 1732 1678 1276 494 532
[Co2(PymL)Cl3] (3) 1582 1728 1654 1265 480 512
[Zn2(PymL)(OAc)3] (4) 1596 1742 1672 1252 488 528
azo. = azomethine group, carbox. = carboxyl group, pym. = pyrimidine ring, OAc = CH3COO.
50 A.N. Srivastva et al.Yield 78%; m.p.: 194 C; yellow solid. Anal. calc. for
C8H12N2O4 (200.18): C 47.99, H 6.04, N 14.00%. Found: C
47.84, H 5.98, N 13.87%.
2.3. General procedure for synthesis of the binuclear metal
complexes (1–4)
To a methanolic solution of Schiff base (L) (1 mmol, 0.20 g),
methanolic solution of corresponding metal chloride/acetate
salt (2 mmol) [CuCl2Æ2H2O (0.34 g), NiCl2Æ6H2O (0.47 g),
CoCl2Æ6H2O (0.48 g) and Zn(CH3CO2)2ÆH2O (0.44 g)] was
added drop-wise with continuous stirring and solution mixture
was stirred at 60 C for 30 min. Subsequently, a hot aqueous
ethanolic solution of 5-methyl-2,6-pyrimidine-dione (1 mmol,
0.126 g) was added drop-wise and stirred at 65 C for 2 h
and reﬂuxed at 75 C for 10–12 h. The completion of reac-
tion was monitored by thin layer chromatography (TLC).
The solutions were cooled in refrigerator overnight. Coloured
solid products (except Zn(II) complex) of metal complexesFigure 1 IR spectrumwere isolated, ﬁltered off, washed with hot water, MeOH,
EtOH and diethyl ether and dried in vacuum desiccator over
anhydrous calcium chloride (Scheme 2).
2.3.1. Binuclear metal complex [Cu2(PymL)Cl3] (1)
Yield 64%; m.p.: 258 C (dec.); dark brown solid. Anal. calc.
for C13H17N4O6Cl3Cu2 (558.72): C 27.92, H 3.04, N 10.02,
Cu 22.75, Cl 19.06%. Found: C 27.86, H 2.98, N 9.96, Cu
22.68, Cl 18.97%. Molar conductance KM: 8.20 O
1
cm2 mol1. leff: 1.92 BM. UV–visible (DMSO), kmax: 602 nm.
2.3.2. Binuclear metal complex [Ni2(PymL)Cl3] (2)
Yield 68%; m.p.: 244 C (dec.); brown solid. Anal. calc. for
C13H17N4O6Cl3Ni2 (548.92): C 28.41, H 3.10, N 10.20, Ni
21.39, Cl 19.40%. Found: C 28.36, H 3.07, N 10.13, Ni
21.31, Cl 19.32%. Molar conductance KM: 7.60 O
1
cm2 mol1. leff: 3.08 BM. UV–visible (DMSO), kmax: 378,
466, 633, 708 nm.of Schiff base (L).
Figure 2 IR spectrum of complex [Cu2(PymL)Cl3].
Figure 3 IR spectrum of complex [Ni2(PymL)Cl3].
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Figure 4 IR spectrum of complex [Co2(PymL)Cl3].
52 A.N. Srivastva et al.2.3.3. Binuclear metal complex [Co2(PymL)Cl3] (3)
Yield 61%; m.p.: 272 C (dec.); reddish brown solid. Anal.
calc. for C13H17N4O6Cl3Co2 (549.40): C 28.40, H 3.12, N
10.20, Co 21.45, Cl 19.35%. Found: C 28.36, H 3.06, N
10.16, Co 21.41, Cl 19.30%. Molar conductance KM:
5.20 O1 cm2 mol1. leff: 4.86 BM. UV–visible (DMSO), kmax:
382, 400, 660, 732 nm.
2.3.4. Binuclear metal complex [Zn2(PymL)(CH3CO2)3] (4)
Yield 67%; m.p.: 238 C (dec.); colourless. Anal. calc. for C19-
H26N4O12Zn2 (633.16): C 36.04, H 4.14, N 8.85, Zn 20.65%.
Found: C 35.98, H 4.10, N 8.78, Zn 20.60%. Molar conduc-
tance KM: 3.10 O
1 cm2 mol1. UV–vis (DMF), kmax: 322 nm.
2.4. Physical measurements
Elemental analysis (C, H, and N) was performed using a Vari-
oEL elementar analysensysteme. Metals and chlorides were
estimated volumetrically (Reilley et al., 1959) and gravimetri-
cally (Vogel, 1961), respectively. Melting points were recorded
on an electro-thermal melting point apparatus and are uncor-
rected. IR spectra were recorded as KBr discs using a Shima-
dzu 8300 IR spectrophotometer covering the frequency range
4000–400 cm1. Electronic absorption spectra in the 200–
900 nm range were obtained in DMF on a Systronic UV–visi-
ble spectrophotometer at room temperature. 1H NMR and 13C
NMR spectra (at room temperature, in DMSO-d6) were
recorded on a Bruker Avance II 400 NMR spectrometer.The chemical shift (d) was measured down ﬁeld with reference
to TMS (tetramethylsilane, 0.0 ppm). ESI-MS spectra were
obtained on an AB-Sciex Q-Star LCMS-MS spectrometer.
Molar conductance measurements were determined in DMSO
(103 M) at room temperature using a Jenway Model 4070
conductivity meter. Magnetic moment measurements were car-
ried out by the Gouy method using Hg[Co(SCN)4] as cali-
brant. EPR spectra of Cu(II) and Co(II) complexes were
recorded as polycrystalline sample on a Varian E-112 spec-
trometer at the X-band region with frequency of 9.1 GHz
under the magnetic ﬁeld strength 3200 G using TCNE (tetracy-
anoethylene) as ﬁeld marker (g= 2.0027).
2.5. In vitro antimicrobial activities
2.5.1. In vitro antibacterial activity
Synthesized Schiff base (L) and binuclear complexes were
screened for their in vitro antibacterial activities against two
Gram positive (Staphylococcus aureus and Bacillus subtilis)
and two Gram negative (Escherichia coli and Salmonella typhi)
bacteria by using the Agar well diffusion method (Sadan et al.,
2003; Rahman et al., 2001). Streptomycin was used as refer-
ence antibacterial drug. Bacterial strains stored in Mueller–
Hinton broth (Merck), were subcultured for testing in the same
medium and grown at 37 C. The test compounds (Schiff base,
metal complexes and streptomycin) were dissolved in DMSO
at a concentration of 2 mg/ml. Stock solutions were prepared
and dilutions were made according to the guidelines in NCCLS
(National Committee for Clinical Laboratory Standards, 1997)
Figure 5 IR spectrum of complex [Zn2(PymL)(CH3CO2)3].
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broth procedure. Microbial cells were suspended according to
the 0.5 McFarland protocol in saline solution to produce a sus-
pension of 104–106 CFU (colony forming unit) per ml. Serial
dilutions of test compounds were prepared in test tubes to ﬁnal
concentrations of 1024, 512, 256, 128, 64, 32, 16, 8, 4, 2 lg/ml.
All strains were incubated at 37 C for 24 h with different con-
centrations of compounds in Mueller–Hinton broth. Wells
were created in medium with the help of a sterile metallic borer
of 6 mm diameter and nutrient agar media was prepared in
1000 ml of distilled water. The pH of solutions was adjusted
to 7.1 by adding appropriate amount of sodium hydroxide.
The resulting solution was autoclaved for 35 min at 12 psi
and seeded with 100 ll of prepared inocula containing approx-
imately 106 CFU/ml. 70 ml of seeded nutrient agar was poured
to prepare petriplates. The antibacterial activity was deter-
mined by measuring the diameter of the inhibition zone (in
mm). For quantitative measurement of growth inhibition, cal-
culation was done according to procedure described in the lit-
erature (Rahman et al., 2001). The minimum inhibition
concentrations of each compound were recorded as the lowest
concentration of each chemical compound in the tubes with no
growth (i.e., no turbidity) of inoculated bacteria. Each assay
was performed in duplicate and repeated three times.
2.5.2. In vitro antifungal activity
Poisoned food technique was used to check the in vitro anti-
fungal activity of synthesized Schiff base and binuclear com-
plexes against two fungi Candida albicans and Candidaparapsilosis (Al-Burtamani et al., 2005). Fungal strains were
grown on Sabouraud dextrose agar (SDA) at 28 C for 7 days.
For performing antifungal activity of test compounds one
week old fungal culture was used as inoculums. Fluconazole
was used as reference antifungal drug and the medium with
DMSO as solvent was used as a negative control. Solution
of the test compounds (Schiff base and metal complexes) and
reference drug were dissolved in DMSO at a concentration
of 2 lg/ml. Molten SDA was poisoned by the addition of
100 ll of prepared inocula and poured into sterile petriplates.
The prepared plates containing the test compound were inoc-
ulated with fungal plugs (6 mm diameter) obtained from the
activity growing margins of fungal plates. Plates were inocu-
lated at 28 C for one week. Each assay was performed in
duplicate and repeated three times. Antifungal activity data
of compounds were expressed as percent inhibition calculated
from the diameter of inhibition zone. The percent inhibition
was determined using the formula:
% Inhibition ¼ ðC TÞ:100=C
where C is the diameter of the fungal colony in the control
plate and T is the diameter of the microbial colony in the tested
plate after same incubation period.
3. Results and discussion
The Schiff base (L) was synthesized by the condensation of an
aqueous solution of glycine and ethanolic solution of
2,3-butanedione in 2:1 M ratio. Template condensation of
Table 2 1H NMR and 13C NMR spectral data of the Schiff base (L) and [Zn2(PymL)(CH3CO2)3] complex (4) (in DMSO-d6) at room
temperature with reference to TMS (tetramethylsilane).
Compounds 1H NMR (d/ppm) 13C NMR (d/ppm)
(L)
C
1
HO
2
O
3
CH2
4
N
5C
6
CH3
7
C
8
CH3
C OHO
N CH2
1.32 [‚CACH3 (s, 6H)], 3.54
[ACH2 (s, 4H)], 11.22 [AOH (s, 2H)]
13.40 [C-4, 6], 46.90 [C-2, 7],
161.50 [C-3, 5], 173.40 [C-1, 8]
[Zn2(PymL)(CH3CO2)3]
(4)
C
8
HO O
CH2
7
N
C5
CH3
6
C3
CH3
4
C
1
OHO
N CH2
2
NH
9
10
11
12
N OO
H3C
13
Zn OOCCH3CH3COO
Zn
OOCCH3
1414` 1515`
16 17
1.12 [‚CACH3 (s, 6H)], 1.74 [-CH3
(pym.) (s, 3H)], 2.17 [ACH3COO
(br, s, 9H)], 3.68 [ACH2 (s, 4H)], 7.34
[ACH (s, 1H), (pym.)], 10.90 [ANH
(pym.) (br, s, 1H)], 11.32 [AOH (s, 2H)]
13.10 [C-4, 6], 15.20 [C-13],
18.96 [C-15, 15‘, 17], 46.20 [C-2, 7],
106.30 [C-11], 138.40 [C-10], 158.90
[C-3, 5], 160.80 [C-12], 169.80 [C-1, 8],
173.20 [C-14, 14‘, 16], 178.10 [C-9]
pym. = pyrimidine ring.
54 A.N. Srivastva et al.synthesized Schiff base (L), 5-methyl-2,6-pyrimidine-dione and
corresponding metal chloride/acetate salt in 1:1:2 M ratio gives
binuclear metal complexes (1–4) of general formula [M2-
(PymL)X3]. The newly synthesized Schiff base (L) and metal
complexes are stable at room temperature in solid state. Schiff
base is soluble in MeOH and EtOH but metal complexes are
soluble in DMF and DMSO. Analytical and spectral data
are consistent with the proposed molecular formula and struc-
ture of Schiff base (L) and binuclear metal complexes. The
positions of the molecular ion peaks in the mass spectra of
compounds are consistent with their empirical molecular for-
mulae and formula weight. Molar conductance measurement
values show non-electrolytic nature of complexes as the value
falls in the range 3.10–8.20 O1 cm2 mol1 (Geary, 1971). On
the basis of electronic spectral data, EPR spectral data and
magnetic moment values, octahedral geometry was assigned
for all binuclear metal complexes.
3.1. IR spectra
The most relevant IR spectral bands of Schiff base (L) and
binuclear complexes (1–4) are given in Table 1. In the IR spec-
trum of Schiff base (L), there are no bands of the free –NH2group (3400 cm1) and ketonic group (1720 cm1) (Fig. 1).
The absence of these bands and appearance of a new band
at 1618 cm1 which may be assigned to the azomethine group
[m(AC‚N)] vibration, indicate the condensation of the amino
group of glycine with the carbonyl group of 2,3-butanedione
and formation of proposed Schiff base (Singh et al., 2006;
Majumdar et al., 2002; Dolze et al., 2004). The appearance
of band at 1768 cm1 and 3648 cm1 may be assigned to the
m(AC‚O) and m(AOH) group of carboxylic acid group,
respectively. The IR spectra of all metal complexes show sig-
niﬁcant changes compared to free Schiff base (L) (Figs. 2–5).
The appearance of band in the range 1582–1596 cm1 suggests
participation of the azomethine group [t(C‚N)] in complex
formation (Singh et al., 2010). The appearance of band in
the range of 1248–1276 cm1 may be assigned for the coordi-
nated [‚CAN] group of pyrimidine ring (Nakamoto, 1986).
The participation of N-atom of the azomethine group and
(‚CAN) group of pyrimidine ring in coordination is further
supported by the presence of new bands in the range 480–
498 cm1 which are assignable to m(M-N) vibration
(Srivastava et al., 2014; Bellamy, 1978). The participation of
the C‚O group in the complex formation was ascertained
by the shift of the band at 1728–1742 cm1 and the presence
Figure 6 1H NMR spectrum of Schiff base (L).
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1768 cm1 in (L) and 1690 cm1 in 5-methyl-2,6-pyrimidine-
dione, respectively (Tabassum et al., 2010; Masoud et al.,
2004). This is further supported by the appearance of new
band in the range 512–532 cm1 which may be assigned for
m(M-O) vibration (Kumar et al., 2010). The band in the range
3645–3650 cm1 may be assigned to non-coordinated m(AOH)
vibration of the carboxylic acid group. A band in the range
3070–3078 cm1 may be due to stretching vibration of the het-
erocyclic ANH group of pyrimidine ring. In the IR spectrum
of [Zn2(PymL)(CH3CO2)3], two characteristic bands appeared
at 1560 cm1 and 1304 cm1 which may be assigned to
m(COO) symmetric and m(COO) asymmetric stretching
vibrations of acetate ion, respectively. A difference between
(mas  ms) is 256 cm1 which is greater than 144 cm1 indicates
the coordination of the acetate ion in mono-dentate fashion
with central metal ion (Singh and Srivastava, 2013;
Nakamoto, 1986).
3.1.1. 1H and 13C NMR spectra
The 1H NMR and 13C NMR spectral data of the Schiff base
(L) and [Zn2(PymL)(CH3CO2)3] complex were recorded in
DMSO-d6 (Table 2). The absence of the signal corresponding
to primary amine proton in the 1H NMR spectrum of Schiff
base (L) suggests the formation of proposed Schiff base (L)(Fig. 6). In the 1H NMR spectrum of Zn(II) complex, signals
of the (CH3AC‚N) and (ACH2A) protons of Schiff base (L)
as well as the (ANH) and (ACH) protons of pyrimidine ring
shifted compare to the starting material which suggests coordi-
nation through nitrogen atom of the azomethine group and
(CAN) group of pyrimidine ring and oxygen atom of the
(C‚O) group of (L) and 5-methyl-2,6-pyrimidine-dione
(Fig. 7). The presence of sharp singlet at 11.32 ppm suggests
that the (AOH) group did not participate in coordination
and broad singlet at 10.90 ppm for one proton suggests that
only one (ANH) group participated in complex formation
(Silverstein et al., 1974). In the 13C NMR spectrum of Zn(II)
complex, change in the chemical shift values compared to the
starting materials revealed coordination through nitrogen
atom of the azomethine group and (CAN) group of pyrimidine
ring and oxygen atom of the (C‚O) group of (L) and 5-
methyl-2,6-pyrimidine-dione (Fig. 8). Thus, 1H and 13C
NMR spectral data support proposed structure of Schiff base
and metal complexes (Srivastava et al., 2014; Silverstein et al.,
1974).
3.2. Mass spectra
The formation of Schiff base (L) and metal complexes (1–4)
was studied with ESI-MS spectra. The proposed molecular for-
Figure 7 1H NMR spectrum of complex [Zn2(PymL)(CH3CO2)3].
56 A.N. Srivastva et al.mula of these compounds was conﬁrmed by comparing their
molecular formula weight with m/z values. In the mass spectra
of compounds, peaks were attributed to the molecular ions; m/
z: 201.16 [M+1]+ for compound (L), m/z: 559.56 [M+1]+ for
compound (1), m/z: 549.90 [M+1]+ for compound (2), m/z:
550.32 [M+1]+ for compound (3) and m/z: 634.16 [M+1]+
for compound (4). These data are in good agreement with
the proposed molecular formula of synthesized compounds.
In addition to the peaks due to the molecular ion, the spectra
exhibit peaks assignable to various fragments arising from the
thermal cleavage of the compounds. The mass spectrum of
Schiff base (L) is shown in Fig. 9.
3.3. Electronic absorption spectra and magnetic moment
measurements
The electronic absorption spectrum of [Cu2(PymL)Cl3] com-
plex (1) exhibits only one broad band at 602 nm assigned to
2Egﬁ 2T2g transition which is in conformity with octahedral
geometry around the Cu(II) ion (Patil et al., 2010; Lever,
1968). The obtained magnetic moment value (leff) for Cu(II)
complex is 1.92 BM indicating that magnetic exchange occurs
between the two copper sites and also supports octahedral
geometry of Cu(II) complex. The electronic absorption
spectrum of [Ni2(PymL)Cl3] complex (2) displays bands at708 nm, 633 nm and 466 nm due to 3A2(g)(F)ﬁ 3T2g(F),
3A2(g)(F)ﬁ 3T1g(F) and 3A2(g)(F)ﬁ 3T1g(P) transitions,
respectively (Patil et al., 2010; Lever, 1968; Shukla et al.,
2008). The absorption spectra of complex also display a band
at 378 nm assigned to charge transfer transition from ligand to
metal ion (LMCT). The Ni(II) complex showed the magnetic
moment value (leff) 3.08 BM which is consistent with octahe-
dral geometry of complex (Alaghaz and Ammar, 2010). The
electronic absorption spectrum of [Co2(PymL)Cl3] complex
(3) exhibits absorption bands at 732 nm, 660 nm and 400 nm
which may be assigned to 4T1g(F)ﬁ 4T2g(F), 4T1g(F)ﬁ
4A2g(F) and
4T1g(F)ﬁ 4T1g(P) transitions, respectively, indi-
cating octahedral geometry of Co(II) complex (Patil et al.,
2010; Lever, 1968; Chandra and Gupta, 2002). In addition, a
band observed at 382 nm attributed to charge transfer transi-
tion from the ligand to metal ion (LMCT). Furthermore, octa-
hedral geometry for Co(II) complex is also supported by its
magnetic moment value (leff) at room temperature which is
4.86 BM (Alaghaz and Ammar, 2010; Alaghaz, 2008). The
electronic absorption spectrum of [Zn2(PymL)(CH3CO2)3]
complex (4) exhibits only a high intense band at 322 nm assign-
able to charge transfer transition from the ligand to metal ion
(LMCT) (Lever, 1968). The Zn(II) complex is diamagnetic as
expected and its geometry is most probably octahedral similar
to Cu(II), Ni(II) and Co(II) complexes.
Figure 8 13C NMR spectrum of Schiff base (L).
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complexes
The X-band EPR spectrum of Cu(II) complex was recorded at
frequency of 9.1 GHz under the magnetic ﬁeld strength 3200 G
at room temperature (298 K) and Co(II) complex at liquid
nitrogen temperature (77 K) as polycrystalline sample and
their gk and g^ values were determined from EPR spectra
and gav values were calculated from the formula
g2av = (g
2
k + 2 g
2
^)/3. The analysis of the EPR spectrum of
Cu(II) gives gk 2.0822, g^ 2.0814 and gav 2.080. The Cu(II)
complex shows a single absorption band. The absence of
hyperﬁne lines in the spectrum of complex may be due to the
strong dipolar and exchange interaction between the Cu(II)
ions in the unit cell. The trend gk > g^> 2.002 observed for
the complex under the study indicates that the unpaired elec-
tron is localized in the dx2  y2 orbital of Cu(II) ion
(Herrera et al., 2003). The analysis of the EPR spectrum of
Co(II) gives gk 2.3142, g^ 2.0042 and gav 2.112. The trend
gk > g^> 2.002 observed for the Co(II) complex under the
study is due to a large angular momentum contribution. Thus,
EPR values also support octahedral geometry of Cu(II) and
Co(II) complexes (Srivastava et al., 2014; Chandra et al.,
2010).3.5. In vitro antibacterial activity
In vitro antibacterial activity of synthesized compounds and
standard drug Streptomycin were screened separately against
two Gram positive bacteria (Staphylococcus aureus and B. sub-
tilis) and two Gram negative bacteria (E. coli and S. typhi).
Agar well diffusion technique was used to evaluate antibacte-
rial activity of compounds (Ferrari et al., 1999) and antibacte-
rial activity data are given in Table 3. Antibacterial activity
data show that the binuclear metal complexes were more toxic
than Schiff base (L) and it is also concluded that metal com-
plexes show more toxicity towards Gram positive strains than
Gram negative strains. The reason is the difference in the com-
plexity of structure of the cell walls of Gram positive and
Gram negative bacteria. The zones of inhibition (ZOI) values
obtained indicate that Schiff base (L) has a signiﬁcant activity
against Staphylococcus aureus but moderate activity against B.
subtilis, E. coli and S. typhi. Complex [Cu2(PymL)Cl3] exhibits
an excellent activity against Staphylococcus aureus and B. sub-
tilis, and good activity against E. coli and S. typhi. Complex
[Ni2(PymL)Cl3] shows a good activity against Staphylococcus
aureus, B. subtilis and S. typhi but a signiﬁcant activity against
E. coli. Complex [Co2(PymL)Cl3] exhibits a good activity
against B. subtilis, signiﬁcant activity against Staphylococcus
Figure 9 ESI-MS spectrum of Schiff base (L).
Table 3 Antibacterial screening data of Schiff base (L), binuclear metal complexes (1–4) and standard drug. Agar well diffusion
technique was used to evaluate the antibacterial activity of synthesized compounds.
Microorganism (L) Metal complexes Streptomycin
1 2 3 4
Gram-positive
Staphylococcus aureus ++ ++++ +++ ++ ++ ++++
Bacillus subtilis + ++++ +++ +++ ++ ++++
Gram-negative
Escherichia coli + +++ ++ + + ++++
Salmonella typhi + +++ +++ ++ + ++++
++++= excellent activity (90–100% inhibition), +++= good activity (60–70% inhibition), ++= signiﬁcant activity (30–50% inhi-
bition), + =moderate activity (10–20%), size of well = 6 mm (diameter), (L) = Schiff base, complex 1 = [Cu2(PymL)Cl3], complex
2 = [Ni2(PymL)Cl3], complex 3 = [Co2(PymL)Cl3], complex 4 = [Zn2(PymL)(CH3CO2)3], streptomycin = standard drug.
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plex [Zn2(PymL)(CH3CO2)3] exhibits a signiﬁcant activity
against Staphylococcus aureus and B. subtilis but moderate
activity against E. coli and S. typhi. The variation in the anti-
microbial activity of different metal complexes against differ-
ent microorganisms depends on the impermeability of the
cell or the differences in ribosomes in microbial cell
(Sengupta et al., 1998). The lipid membrane surrounding the
cell wall favours the passage of any lipid soluble materials
and it is known that liposolubility is an important factor con-
trolling antimicrobial activity (Parekh et al., 2005).3.6. Minimum inhibitory concentration (MIC)
The antibacterial screening concentrations of the compounds
were estimated from the minimum inhibitory concentration
(MIC) value. The MIC values of compounds against Staphylo-
coccus aureus, B. subtilis, E. coli and S. typhi were found to be
64, 64, 128 and 128 lg/ml for Schiff base (L); 16, 16, 32 and
32 lg/ml for [Cu2(PymL)Cl3] complex; 32, 16, 32 and 32 lg/
ml for [Ni2(PymL)Cl3] complex; 32, 16, 32 and 64 lg/ml for
[Co2(PymL)Cl3] complex; 32, 32, 64 and 64 lg/ml for
[Zn2(PymL)(CH3CO2)3] complex; 4, 4, 8 and 8 lg/ml for
Table 4 Minimum Inhibition Concentration (MIC)* values of Schiff base (L), binuclear metal complexes (1–4) and standard drug.
Microorganism Ligand Metal complexes Streptomycin
1 2 3 4
Gram positive
Staphylococcus aureus 64 16 32 32 32 4
Bacillus subtilis 64 16 16 16 32 4
Gram negative
Escherichia coli 128 32 32 32 64 8
Salmonella typhi 128 32 32 64 64 8
* = lg/ml, (L) = Schiff base, complex 1 = [Cu2(PymL)Cl3], complex 2 = [Ni2(PymL)Cl3], complex 3 = [Co2(PymL)Cl3], complex
4 = [Zn2(PymL)(CH3CO2)3], streptomycin = standard drug.
Table 5 Antifungal screening data of Schiff base (L), binu-
clear metal complexes (1–4) and standard drug. Poison food
technique was used to evaluate the antifungal activity of
synthesized compounds.
Compounds Mycelial growth inhibition (%)
a b
(L) 38.2 36.3
[Cu2(PymL)Cl3] (1) 56.2 51.3
[Ni2(PymL)Cl3] (2) 59.6 56.4
[Co2(PymL)Cl3] (3) 54.8 54.5
[Zn2(PymL)(CH3CO2)4] (4) 48.3 42.8
Fluconazole 79.8 85.3
(L) = Schiff base, a = Candida albicans, b = Candida parapsilosis,
ﬂuconazole = standard drug.
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show that the [Cu2(PymL)Cl3] complex was found more potent
as compared to other studied complexes (Table 4).
3.7. In vitro antifungal activity
In vitro antifungal activities of synthesized Schiff base (L) and
binuclear metal complexes were carried out against two fungi
C. albicans and C. parapsilosis and compared with standard
antifungal drug Fluconazole at the same concentration. Anti-
fungal activity data are given in Table 5 which indicate that
metal complexes are more toxic than Schiff base (L). Among
all synthesized compounds, [Ni2(PymL)Cl3] complex is the
most active against studied fungi and shows the highest activ-
ity against C. albicans. The activity is greatly enhanced at
higher concentrations. DMSO control has shown a negligible
activity as compare to the metal complexes and Schiff base.
All the metal complexes exhibited a good antifungal activity
against C. albicans and C. parapsilosis as compared to the stan-
dard drug Fluconazole. Antifungal activity data show that
activity of complexes depends upon the type of metal ion pres-
ent in the complex and it is observed that [Ni2(PymL)Cl3] com-
plex is the most active and [Zn2(PymL)(CH3CO2)3] complex is
the least active, whereas [Cu2(PymL)Cl3] and [Co2(PymL)Cl3]
complexes are active against the studied fungi. In the present
study low activity of some metal complexes may be due to their
low lipophilicity, because of which penetration of the complex
through the lipid membrane was decreased and hence, theycould neither block nor inhibit the growth of the microorgan-
ism. Increased activity of the metal chelates can be explained
on the basis of chelation theory. On chelation, the polarity
of the metal ion will be reduced to a greater extent due to over-
lap of the ligand orbital and partial sharing of the positive
charge of the metal ion with donor groups. Further, it
increases the delocalization of p-electrons over the whole che-
late ring and enhances the penetration of the complexes into
lipid membranes and blocking of the metal binding sites in
enzymes of microorganism. These complexes also disturb the
respiration process of the cell and thus block the synthesis of
proteins, which restricts further growth of microorganism
(Dharmaraj et al., 2002).
The biological activity of compounds also depends on the
nature of the ligand, concentration, nature of metal ion, nature
of anion surrounding the metal ion, coordinating sites and
geometry of complexes. As the mechanism of inhibition by
[Zn2(Pym)L.(CH3CO2)3] complex might be different, it was
observed that Zn(II) complex showed lesser antimicrobial
activity as compared to other synthesized metal complexes
(Vanpariya et al., 2010).
4. Conclusion
Binuclear complexes of Cu(II), Ni(II), Co(II) and Zn(II) metal
ions were synthesized by template condensation of a novel
Schiff base derived from glycine using 2,3-butanedione and
5-methyl-pyrimidine-2,6-dione promoted by the corresponding
metal chloride/acetate salt. A comparative physicochemical
and spectral study of synthesized compounds has been done
which provides excellent data which is in the agreement with
the proposed structure and composition of Schiff base and
metal complexes. IR spectral data reveal that Schiff base coor-
dinates through two nitrogen atoms of azomethine groups and
two oxygen atoms of carboxylic groups, whereas pyrimidine
moiety coordinates with metal ion through two oxygen atoms
of carbonyl groups and one nitrogen atom of pyrimidine ring.
Electronic absorption spectra, EPR spectra and magnetic
moment values suggest octahedral geometry around metal
ions. Low molar conductance values show non-electrolyte nat-
ure of metal complexes. In vitro antibacterial and antifungal
studies show that Schiff base (L) and binuclear metal com-
plexes are biologically active. [Cu2(PymL)Cl3] complex (1)
shows the best activity against bacteria and [Ni2(PymL)Cl3]
complex (2) shows the best activity against fungi studied.
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